NFKB1 and cancer: Our results revealed SBSN_HUMAN[225–237] and SBSN_HUMAN[243–259] to be novel endogenous stimulators of NF-κB and inducers of cytokines, chemokines and growth factors, which are well-known to play pivotal roles in inflammation and cancer biology.